Get the Stockscreener App
0.2453
1.96%
-0.0049
Pre-market:
.25
0.0047
+1.92%
Accuray Inc stock is traded at $0.2453, with a volume of 319.58K.
It is down -1.96% in the last 24 hours and down -11.83% over the past month.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
See More
Previous Close:
$0.2502
Open:
$0.2503
24h Volume:
319.58K
Relative Volume:
0.25
Market Cap:
$29.30M
Revenue:
$436.97M
Net Income/Loss:
$-35.62M
P/E Ratio:
-0.8223
EPS:
-0.2983
Net Cash Flow:
$-10.71M
1W Performance:
-8.06%
1M Performance:
-11.83%
6M Performance:
-33.77%
1Y Performance:
-84.38%
1-Day Range:
$0.2439
$0.256
1-Week Range:
$0.2377
$0.2822
52-Week Range:
$0.22
$2.10
Accuray Inc Stock (ARAY) Company Profile
Name
Accuray Inc
Sector
Industry
Phone
608-824-2800
Address
1240 DEMING WAY, MADISON, CA
Compare ARAY vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARAY
Accuray Inc
|
0.2453 | 29.88M | 436.97M | -35.62M | -10.71M | -0.2983 |
ABT
Abbott Laboratories
|
103.09 | 176.41B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
93.80 | 116.35B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
281.87 | 105.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.05 | 62.29B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.52 | 48.63B | 6.30B | 1.07B | 1.09B | 1.8406 |
Accuray Inc Stock (ARAY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-24 | Initiated | ROTH MKM | Buy |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Dec-22-21 | Initiated | Loop Capital | Buy |
| Jan-21-20 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-01-18 | Upgrade | Citigroup | Sell → Neutral |
| Dec-13-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-30-17 | Initiated | Lake Street | Buy |
| Dec-14-16 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-22-15 | Initiated | RBC Capital Mkts | Sector Perform |
| Nov-12-15 | Initiated | Citigroup | Sell |
| May-01-15 | Reiterated | Dougherty & Company | Buy |
| Jan-12-15 | Initiated | Northland Capital | Outperform |
| Jan-31-14 | Reiterated | Dougherty & Company | Buy |
| Jan-29-14 | Reiterated | Brean Capital | Buy |
| Nov-11-13 | Reiterated | Dougherty & Company | Buy |
| Aug-29-13 | Reiterated | Dougherty & Company | Buy |
| Sep-20-11 | Reiterated | Ticonderoga | Buy |
| Feb-08-10 | Upgrade | Jefferies & Co | Hold → Buy |
| Dec-09-09 | Upgrade | UBS | Sell → Neutral |
| Mar-09-09 | Downgrade | Soleil | Buy → Hold |
| Jan-30-09 | Upgrade | Piper Jaffray | Neutral → Buy |
| Dec-22-08 | Reiterated | Jefferies & Co | Hold |
| Aug-20-08 | Reiterated | Jefferies & Co | Hold |
View All
Accuray Inc Stock (ARAY) Latest News
Accuray, RaySearch to Collaborate on Adaptive Radiation Therapy - Bitget
Accuray And Raysearch Agree To Collaboration Integrating Raystation Software - TradingView
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities - TradingView
Accuray and RaySearch agree to collaboration integrating RayStation software with Accuray platforms to accelerate Accuray’s online adaptive capabilities - TradingView
Accuray (NASDAQ: ARAY) clears 6.8M shares for investors to resell - Stock Titan
TCW GROUP INC Adds to Accuray Inc (ARAY) Stake -- Shares Trade 7 - GuruFocus
Accuray Stock Price Forecast. Should You Buy ARAY? - StockInvest.us
Accuray Inc (ARAY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Accuray swaps $40M debt for equity, raises $15M cash from TCW - scanx.trade
Accuray Inc (NASDAQ: ARAY) Discloses 18.7% Beneficial Ownership by TCW Including Warrants - Kalkine Media
Accuray | 4: Statement of changes in beneficial ownership of securities-10% Owner TCW GROUP INC - Moomoo
[SCHEDULE 13D/A] ACCURAY INC Amended Major Shareholder Report - Stock Titan
Balance Sheet Rescue Meets China Drag in Accuray’s (ARAY) Mixed Quarter - Yahoo Finance
Accuray Inc FY 2026: Revenue $401.95M, EPS ($0.4) — 10-K Summary - TradingView
Accuray (ARAY) sends definitive proxy to shareholders - Stock Titan
Penny-priced Accuray (NASDAQ: ARAY) warrants set up lender share resales - Stock Titan
Accuray Inc - TradingKey
Accuray Fiscal Q4 Swings to Loss, Revenue Falls - Moomoo
ARAY|Accuray Inc|Price:0.295|Chg%:-0.020 - TradingKey
Accuray Inc (ARAY) (Q4 2026) Earnings Call Highlights: Strategic - GuruFocus
ARAY Looks 77.3% Undervalued on GF Value™ Despite Financial Chal - GuruFocus
Accuray Incorporated Q4 2026 Earnings Call Summary - Yahoo Finance
Accuray earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
Accuray Incorporated Q4 Operating Expenses US - Moomoo
Aug 19 (Reuters)Accuray Incorporated Q4 Ne - Moomoo
Accuray (ARAY) Telefonkonferenz zu den Ergebnissen des 4. Quartals des Geschäftsjahres 2026: Servicewachstum, Rückgang der Produktumsätze - TradingKey
Earnings call transcript: Accuray posts mixed Q4 2026 results as revenue slips - Investing.com Canada
Accuray Q4 2026 Earnings Call: Complete Transcript - Benzinga
Accuray Incorporated reports results for the quarter ended June 30Earnings Summary - TradingView
Is Accuray Inc (ARAY) a Value Trap After Q4 Earnings Miss? EPS - GuruFocus
Accuray Reports Fourth Quarter and Fiscal 2026 Financial Results - investingnews.com
Accuray Q4 Results: EPS beats estimate, sales miss by 4.16% - scanx.trade
ARAY Looks 78.0% Undervalued on GF Value™ but Faces Profitabilit - GuruFocus
ARAY Looks 78.0% Undervalued on GF Value™ - GuruFocus
Accuray: Fiscal Q4 Earnings Snapshot - marketscreener.com
Accuray posts narrower-than-feared Q4 loss as cost cuts exceed targets - Investing.com Canada
Accuray Q4 FY2026 Earnings: Margin Expands Despite Product Revenue Decline - TradingKey
Accuray Reports $100.9 Million Fourth-Quarter Revenue and $1.9 Million Net Loss - Quiver Quantitative
BRIEF-Accuray Incorporated Q4 Revenue USD 100.919 Million - TradingView
Accuray Incorporated Reports Earnings Results for the Fourth Quarter Ended June 30, 2026 - marketscreener.com
Accuray Inc (ARAY:UR): Stock Price, Quote and News - BNN Bloomberg
Accuray (ARAY) Trading Summary: Falls 3.55% to $0.32 for the Current Session; Session Range View: Support at $0.30 and Resistance at $0.34 Frame the Range in the Available RecordHidden Order - vinanet.vn
ARAY Looks 76.5% Undervalued on GF Value™ - GuruFocus
Accuray Incorporated expected to post a loss of 10 cents a shareEarnings Preview - TradingView
Earnings Preview: Accuray to Report Financial Results Post-market on August 19 - Moomoo
Accuray Inc (ARAY) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments - TradingView
Accuray names two executives to lead transformation efforts By Investing.com - Investing.com Canada
Accuray (NASDAQ: ARAY) seeks approval for $55M recapitalization, dilution and reverse split - Stock Titan
Accuray | PRE 14A: Preliminary proxy statements relating to merger or acquisition - Moomoo
Neuberger Berman Group LLC Trims Accuray Inc (ARAY) Stake -- Sha - GuruFocus
Accuray Inc Stock (ARAY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Accuray Inc Stock (ARAY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Peralta Leonel | SVP, Chief Operations Officer |
Feb 28 '26 |
Option Exercise |
0.00 |
83,723 |
0 |
83,723 |
| MAYER STEVEN F | Director |
Feb 20 '26 |
Buy |
0.56 |
54,875 |
30,878 |
1,545,620 |
| MAYER STEVEN F | Director |
Feb 18 '26 |
Buy |
0.53 |
126,125 |
67,199 |
1,421,745 |
| MAYER STEVEN F | Director |
Feb 19 '26 |
Buy |
0.53 |
69,000 |
36,598 |
1,490,745 |
| Scott Byron C | Director |
Dec 31 '25 |
Option Exercise |
0.00 |
9,433 |
0 |
162,727 |
3.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):